Free Trial

Kirin (KNBWY) Expected to Announce Earnings on Tuesday

Kirin logo with Consumer Staples background

Key Points

  • Kirin is expected to release its quarterly earnings on August 5th, forecasting earnings of $0.28 per share and revenue of $608.48 billion.
  • In the previous quarter, Kirin reported earnings of $0.20 per share, missing estimates, and revenue of $3.58 billion, below analyst expectations.
  • As of Tuesday, shares of Kirin opened at $13.44, down by 1.0%, with a market capitalization of $10.88 billion.
  • MarketBeat previews top five stocks to own in September.

Kirin (OTCMKTS:KNBWY - Get Free Report) will likely be releasing its earnings data before the market opens on Tuesday, August 5th. Analysts expect Kirin to post earnings of $0.28 per share and revenue of $608.48 billion for the quarter.

Kirin (OTCMKTS:KNBWY - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.21 by ($0.01). Kirin had a return on equity of 3.75% and a net margin of 2.37%. The firm had revenue of $3.58 billion during the quarter, compared to the consensus estimate of $3.74 billion.

Kirin Stock Performance

Shares of KNBWY stock traded up $0.17 during mid-day trading on Friday, reaching $13.42. The stock had a trading volume of 106,524 shares, compared to its average volume of 71,172. The firm's 50 day simple moving average is $13.98 and its 200 day simple moving average is $13.89. The company has a quick ratio of 0.72, a current ratio of 1.15 and a debt-to-equity ratio of 0.54. Kirin has a one year low of $12.25 and a one year high of $16.25. The firm has a market cap of $10.87 billion, a PE ratio of 29.16 and a beta of 0.10.

About Kirin

(Get Free Report)

Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products.

Featured Articles

Earnings History for Kirin (OTCMKTS:KNBWY)

Should You Invest $1,000 in Kirin Right Now?

Before you consider Kirin, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kirin wasn't on the list.

While Kirin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines